Lista de obras -

18F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia ⬇️

artículo científico publicado el 17 de junio de 2011

A high BMI is a risk factor in younger patients with de novo acute myelogenous leukemia

artículo científico publicado en 2015

A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial

artículo científico publicado en 2010

A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy

scientific article published on 19 June 2020

Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

artículo científico publicado en 2015

Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features

artículo científico publicado en 2016

Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD.

artículo científico publicado en 2015

Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse

artículo científico publicado en 2022

Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study

artículo científico publicado en 2019

Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trial

artículo científico publicado en 2014

An exotic cause of exudative enteropathy

artículo científico

Arsenic-induced APL differentiation in cerebrospinal fluid

artículo científico publicado en 2006

Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin

artículo científico publicado en 2018

Characterization of acute myeloid leukemia with del(9q) - Impact of the genes in the minimally deleted region

scientific article published on 17 November 2018

Chlorpromazine combined with cidofovir for treatment of a patient suffering from progressive multifocal leukoencephalopathy

artículo científico publicado en 2007

Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts

scientific article published on 20 August 2019

Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients

artículo científico publicado en 2017

Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2012

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes

artículo científico publicado en 2010

Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study

scientific article published on 23 May 2011

Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of <i>TP53</i> mutations - a registry based analysis

artículo científico publicado en 2021

Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears

artículo científico publicado en 2021

Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML

artículo científico publicado en 2022

Development of the interdisciplinary evidence-based s3 guideline for the diagnosis and treatment of prostate cancer: methodological challenges and solutions

artículo científico publicado en 2010

Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

artículo científico publicado en 2020

EZH2 mutations and impact on clinical outcome - an analysis in 1604 patients with newly diagnosed acute myeloid leukemia

scientific article published on 14 August 2019

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

artículo científico publicado en 2015

Feasibility of azacitidine added to standard chemotherapy in older patients with acute myeloid leukemia--a randomised SAL pilot study

artículo científico publicado en 2012

Focus on academic multicenter trials: impact of the German drug law on hematological/oncological therapy optimization trials

artículo científico

Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy

artículo científico publicado en 2021

High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial

artículo científico publicado en 2013

How I treat hyperleukocytosis in acute myeloid leukemia.

artículo científico publicado en 2015

Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia

artículo científico publicado en 2021

Impact of pharmacokinetics on the toxicity and efficacy of clofarabine in patients with relapsed or refractory acute myeloid leukemia

artículo científico publicado en 2017

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

artículo científico publicado en 2016

Induction of Cellular Immune Responses in Patients With Stage-I Multiple Myeloma After Vaccination With Autologous Idiotype-pulsed Dendritic Cells ⬇️

artículo científico publicado el 1 de enero de 2011

Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells

scientific article published on 21 July 2005

Induction of short-term remission with single agent eltrombopag in refractory nucleophosmin-1-mutated acute myeloid leukemia

artículo científico publicado en 2014

Interventions for mycosis fungoides

artículo científico publicado en 2012

Interventions for mycosis fungoides

artículo científico publicado en 2011

Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis

artículo científico

JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia-Letter

artículo científico publicado en 2018

Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias

artículo científico

Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial

artículo científico publicado en 2017

Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system

artículo científico publicado en 2011

Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failure

scientific article published on 10 August 2019

Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia

artículo científico publicado en 2020

Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

artículo científico publicado en 2018

Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome

artículo científico publicado en 2015

Mixed response after allogeneic haemopoietic-cell transplantation for metastatic renal-cell carcinoma

artículo científico publicado en 2004

Mobilization of PML/RARalpha negative peripheral blood stem cells with a combination of G-CSF and CXCR4 blockade in relapsed acute promyelocytic leukemia pre-treated with arsenic trioxide

artículo científico publicado en 2009

Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2014

Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial

artículo científico publicado en 2011

Radioimmunotherapy in Combination with Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Multiple Myeloma

artículo científico publicado en 2019

Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantation

artículo científico publicado en 2012

Reconstitution of interleukin-17-producing T helper cells after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2012

Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma

artículo científico publicado en 2016

Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study

artículo científico publicado en 2017

Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN)

artículo científico publicado en 2020

Survey and analysis of the efficacy and prescription pattern of sorafenib in patients with acute myeloid leukemia

artículo científico publicado en 2011

Symptomatic central nervous system involvement in adult patients with acute myeloid leukemia

artículo científico publicado en 2017

TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation

artículo científico publicado en 2016

The clinical mutatome of core binding factor leukemia

scientific article published on 02 January 2020

The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: a systematic review

artículo científico publicado en 2009

The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML.

artículo científico publicado en 2013

The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET/CT: final results from the Prospective PETAML Trial

scientific article published on 29 August 2019

Two cycles of risk-adapted consolidation therapy in patients with acute promyelocytic leukemia. Results from the SAL-AIDA2000 trial

artículo científico publicado en 2014

Validation of a Molecular Risk Score for Prognosis of Patients With Acute Promyelocytic Leukemia Treated With All-trans Retinoic Acid and Chemotherapy-containing Regimens

artículo científico publicado en 2017

Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

artículo científico publicado en 2018

Lista de obras de

18F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia ⬇️

A high BMI is a risk factor in younger patients with de novo acute myelogenous leukemia

A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial

A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy

Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features

Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD.

Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse

Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study

Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trial

An exotic cause of exudative enteropathy

Arsenic-induced APL differentiation in cerebrospinal fluid

Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin

Characterization of acute myeloid leukemia with del(9q) - Impact of the genes in the minimally deleted region

Chlorpromazine combined with cidofovir for treatment of a patient suffering from progressive multifocal leukoencephalopathy

Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts

Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients

Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes

Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study

Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of <i>TP53</i> mutations - a registry based analysis

Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears

Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML

Development of the interdisciplinary evidence-based s3 guideline for the diagnosis and treatment of prostate cancer: methodological challenges and solutions

Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

EZH2 mutations and impact on clinical outcome - an analysis in 1604 patients with newly diagnosed acute myeloid leukemia

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

Feasibility of azacitidine added to standard chemotherapy in older patients with acute myeloid leukemia--a randomised SAL pilot study

Focus on academic multicenter trials: impact of the German drug law on hematological/oncological therapy optimization trials

Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy

High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial

How I treat hyperleukocytosis in acute myeloid leukemia.

Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia

Impact of pharmacokinetics on the toxicity and efficacy of clofarabine in patients with relapsed or refractory acute myeloid leukemia

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

Induction of Cellular Immune Responses in Patients With Stage-I Multiple Myeloma After Vaccination With Autologous Idiotype-pulsed Dendritic Cells ⬇️

Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells

Induction of short-term remission with single agent eltrombopag in refractory nucleophosmin-1-mutated acute myeloid leukemia

Interventions for mycosis fungoides

Interventions for mycosis fungoides

Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis

JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia-Letter

Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias

Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial

Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system

Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failure

Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia

Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome

Mixed response after allogeneic haemopoietic-cell transplantation for metastatic renal-cell carcinoma

Mobilization of PML/RARalpha negative peripheral blood stem cells with a combination of G-CSF and CXCR4 blockade in relapsed acute promyelocytic leukemia pre-treated with arsenic trioxide

Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial

Radioimmunotherapy in Combination with Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Multiple Myeloma

Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantation

Reconstitution of interleukin-17-producing T helper cells after allogeneic hematopoietic cell transplantation

Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma

Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study

Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN)

Survey and analysis of the efficacy and prescription pattern of sorafenib in patients with acute myeloid leukemia

Symptomatic central nervous system involvement in adult patients with acute myeloid leukemia

TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation

The clinical mutatome of core binding factor leukemia

The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: a systematic review

The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML.

The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET/CT: final results from the Prospective PETAML Trial

Two cycles of risk-adapted consolidation therapy in patients with acute promyelocytic leukemia. Results from the SAL-AIDA2000 trial

Validation of a Molecular Risk Score for Prognosis of Patients With Acute Promyelocytic Leukemia Treated With All-trans Retinoic Acid and Chemotherapy-containing Regimens

Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation